Zenith Drugs Ltd.
Search Company
Registered Address
Registered Office : K. No. 72 / 5, Village Muradpura, NA, Depalpur,
Indore, Madhya Pradesh - 453001
Tel: 0731-8435501867
Email : info@zenithdrugs.com
Website : www.zenithdrugs.com
Key Officials
Name Designation
Ms. Sakshi Bhawsar Co. Secretary & Compl. Officer
Mr. Neeraj Pandey Chief Financial Officer
Listings
NSE ,  
Standalone Consolidated
You are viewing standalone data.
Quarterly Results
No Data Available for the company selected.
Balance Sheet
Mar 25 Mar 24 Mar 23
Share Capital 17.15 17.15 0.40
Reserve & Surplus 52.23 45.07 17.33
Revaluation Reserve 0.00 0.00 0.00
Networth 69.38 62.22 17.73
Total debt 48.57 23.93 25.42
Total Liability 117.95 86.15 43.15
Net Block 43.36 10.94 10.82
Capital work in progress 0.00 3.91 0.00
Investment 0.00 0.03 0.03
Net current asset 74.59 71.28 32.30
Miscellaneous expenses 0.00 0.00 0.00
Total Assets 117.95 86.15 43.15
Income Statement
  Mar25 Mar24 Mar23
Sales 133.32 131.62 114.52
Other Income 2.61 2.12 1.24
Total Expenses 119.74 114.71 105.47
Operating Profit 13.58 16.92 9.05
Interest 3.71 3.00 2.33
Adjusted PBDIT 16.18 19.04 10.29
Depreciation 2.97 1.30 1.30
Adjusted PBT 9.51 14.74 6.66
Taxation 2.10 3.76 1.78
Net Profit / Loss 7.16 9.54 4.88
Key Ratios
  Mar25 Mar24 Mar23
OPM (%) 10.18 12.85 7.90
GPM (%) 7.95 11.86 6.76
NPM (%) 5.37 7.24 4.26
Earning Retention Ratio 100.00 92.20 100.00
Return on networth (%) 10.32 15.32 27.52
EPS (Rs.) 4.18 5.56 122.03
Dividend payout Ratio 0.00 8.99 0.00
Longterm Debt-Equity Ratio 0.18 0.12 0.43
Current Ratio 2.71 2.48 1.60
Fixed Asset Turnover Ratio 1.31 2.04 3.15
Inventory 1.13 1.53 2.65
Interest coverage Ratio 4.36 6.35 4.42
Registrar Details
No Data Available for the company selected.
BSE
Market Performance
Exchange
Last Traded Price (Rs.)
Last Traded Date
Last Traded Time
Change (%)
Day's Open (Rs.)
Previous Close (Rs.)
Day's High (Rs.)
Day's Low (Rs.)
Volume (Rs. In Lacs)
Bid Price (Rs.)
Bid Quantity
Offer Price (Rs.)
Offer Quantity
Exchange Code
Exchange Group
Board Meetings
Date Purpose
29/05/2025 Audited Results & Others
17/04/2025 To consider Fund Raising & Others
14/11/2024 Quarterly Results
Corporate News
Zenith Drugs - Certificate under SEBI (Depositories and Participants) Regulations, 2018
Zenith Drugs - Reply to Clarification- Financial results
Zenith Drugs - Disclosure under SEBI Takeover Regulations
Zenith Drugs - Clarification - Financial Results
Zenith Drugs - General Updates
Share Holding Pattern as on 31/03/2025
Major Holder No. of Shares Percentage(%)
Promoters 12,000,000 69.98
Institutional Investors 10,400 0.06
Other Investors 755,200 4.40
General Public 4,383,200 25.56